📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NextCure

1.1 - Company Overview

NextCure Logo

NextCure

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical discovery and development focused on next-generation immuno-oncology-based drugs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NextCure

Hepion Pharmaceuticals Logo

Hepion Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical drug development, featuring rencofilstat, a cyclophilin inhibitor aimed at reducing liver fibrosis and hepatocellular carcinoma tumor burden, currently in Phase 2 for NASH, and a proprietary AI/ML platform to understand disease processes and identify patients who respond to rencofilstat, potentially shortening development timelines and enhancing clinical trial outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hepion Pharmaceuticals company profile →
Iconic Therapeutics Logo

Iconic Therapeutics

HQ: United States Website
  • Description: Provider of TF-targeting immunoconjugate proteins and monoclonal antibodies for diseases with Tissue Factor overexpression. Offers a licensed anti-TF fusion protein (hI-con1) from Yale; ophthalmology program for retinal diseases (AMD, diabetic retinopathy); inflammation program to modulate cytokines/chemokines; and an oncology program with Exelixis developing an ADC for solid tumors, in Phase I.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iconic Therapeutics company profile →
Bilthoven Biologicals Logo

Bilthoven Biologicals

HQ: The Netherlands Website
  • Description: Provider of pharmaceutical products manufacturing services and vaccine/diagnostic solutions, including inactivated polio vaccine (IPV), pandemic preparedness vaccine facilities in Europe (capacity over 300 million doses annually), SIILTIBCY tuberculosis skin test, BCG for bladder cancer and TB vaccination, DTP vaccine (diphtheria, tetanus, polio), and tetanus vaccine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bilthoven Biologicals company profile →
Checkmate Pharmaceuticals Logo

Checkmate Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cancer immunotherapy, leveraging expertise in CpG oligonucleotides to discover and develop novel immunotherapies aimed at enabling more people with cancer to benefit from these treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Checkmate Pharmaceuticals company profile →
Sutro Biopharma Logo

Sutro Biopharma

HQ: United States Website
  • Description: Provider of protein therapeutics leveraging OCFS and XpressCF cell-free protein synthesis, with an ADC pipeline: luveltamab tazevibulin (luvelta) targeting folate receptor alpha in clinical studies for platinum-resistant ovarian cancer; STRO-003 (ROR1-targeting) under a global licensing agreement with potential milestones and royalties; STRO-004 (tissue factor-targeting) planned for 2025 IND; plus sustainability efforts and a summer internship program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sutro Biopharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NextCure

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NextCure

2.2 - Growth funds investing in similar companies to NextCure

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NextCure

4.2 - Public trading comparable groups for NextCure

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NextCure

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NextCure

What does NextCure do?

NextCure is a provider of biopharmaceutical discovery and development focused on next-generation immuno-oncology-based drugs.

Who are NextCure's competitors?

NextCure's competitors and similar companies include Hepion Pharmaceuticals, Iconic Therapeutics, Bilthoven Biologicals, Checkmate Pharmaceuticals, and Sutro Biopharma.

Where is NextCure headquartered?

NextCure is headquartered in United States.

How many employees does NextCure have?

NextCure has 1,000 employees 🔒.

When was NextCure founded?

NextCure was founded in 2010 🔒.

What sector and industry vertical is NextCure in?

NextCure is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NextCure

Who are the top strategic acquirers in NextCure's sector and industry

Top strategic M&A buyers and acquirers in NextCure's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NextCure?

Top strategic M&A buyers groups and sectors for NextCure include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NextCure's sector and industry vertical

Which are the top PE firms investing in NextCure's sector and industry vertical?

Top PE firms investing in NextCure's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NextCure's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NextCure's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NextCure's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NextCure include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NextCure's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NextCure?

The key public trading comparables and valuation benchmarks for NextCure include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NextCure for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NextCure with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NextCure's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NextCure with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NextCure's' sector and industry vertical?

Access recent funding rounds and capital raises in NextCure's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NextCure